Purpose: To determine if ocular treatment with topically administered prostamide or prostaglandin analogs can reduce central corneal thickness (CCT). Methods: We retrospectively analyzed the data of glaucomatous patie...Purpose: To determine if ocular treatment with topically administered prostamide or prostaglandin analogs can reduce central corneal thickness (CCT). Methods: We retrospectively analyzed the data of glaucomatous patients who had their CCT measured before and during monotherapy treatment with either latanoprost 0.05%, travoprost 0.004% or bimatoprost 0.03%. 62 patients were qualified for analysis. One eye of each subject was ran-展开更多
Purpose: To determine if there is a correlation between asymmetric glaucomatous visual field (VF) damage and Water Drinking Test (WDT) response. Methods: We retrospectively reviewed the VF and WDT data of glaucomatous...Purpose: To determine if there is a correlation between asymmetric glaucomatous visual field (VF) damage and Water Drinking Test (WDT) response. Methods: We retrospectively reviewed the VF and WDT data of glaucomatous patients with asymmetric mean deviation (MD) but with similar IOP OU (maximum 2mmHg difference between OD and OS). Results: 101展开更多
文摘Purpose: To determine if ocular treatment with topically administered prostamide or prostaglandin analogs can reduce central corneal thickness (CCT). Methods: We retrospectively analyzed the data of glaucomatous patients who had their CCT measured before and during monotherapy treatment with either latanoprost 0.05%, travoprost 0.004% or bimatoprost 0.03%. 62 patients were qualified for analysis. One eye of each subject was ran-
文摘Purpose: To determine if there is a correlation between asymmetric glaucomatous visual field (VF) damage and Water Drinking Test (WDT) response. Methods: We retrospectively reviewed the VF and WDT data of glaucomatous patients with asymmetric mean deviation (MD) but with similar IOP OU (maximum 2mmHg difference between OD and OS). Results: 101
